”He signalled he wanted to look at companies or collaborations in Australia that were developing their own intellectual property or had access to it from others and were capable of completing all the steps in mRNA production.”
this is from the SMH article. I think this fits with IDT and the collaboration they have with Monash University.
Ann: Response to ASX Price Query, page-84
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.8¢ |
Change
-0.003(1.92%) |
Mkt cap ! $55.87M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 12.5¢ | $4.107K | 32.70K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2546 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 517042 | 6 |
View Market Depth
| Last trade - 13.18pm 17/10/2024 (20 minute delay) ? |
| IDT (ASX) Chart |